Treace Medical Concepts, Inc. (TMCI) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $4.18 (+6.76%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Dec 18, 2025 | Richard Newitter | Truist Financial | $3.00 | -28.3% |
| Nov 10, 2025 | Richard Newitter | Truist Financial | $4.00 | -4.4% |
| Feb 4, 2025 | Ryan Zimmerman | BTIG | $16.00 | +282.3% |
| Dec 31, 2024 | Ben Haynor | Lake Street | $14.50 | +246.5% |
| May 16, 2024 | Danielle Antalffy | UBS | $6.50 | +55.3% |
Top Analysts Covering TMCI
TMCI vs Sector & Market
| Metric | TMCI | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.67 | 2.24 | 2.40 |
| Analyst Count | 3 | 8 | 19 |
| Target Upside | -27.5% | +11475.1% | +17.1% |
| P/E Ratio | -2.07 | 3.91 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $205M | $206M | $206M | 4 |
| 2027-03-31 | $52M | $53M | $54M | 1 |
| 2027-06-30 | $49M | $49M | $50M | 2 |
| 2027-09-30 | $53M | $54M | $55M | 2 |
| 2027-12-31 | $76M | $77M | $78M | 1 |
| 2028-03-31 | $58M | $59M | $60M | 1 |
| 2028-06-30 | $55M | $56M | $57M | 1 |
| 2028-09-30 | $60M | $61M | $62M | 1 |
| 2028-12-31 | $83M | $85M | $86M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.92 | $-0.91 | $-0.89 | 2 |
| 2027-03-31 | $-0.27 | $-0.26 | $-0.26 | 1 |
| 2027-06-30 | $-0.27 | $-0.26 | $-0.26 | 1 |
| 2027-09-30 | $-0.22 | $-0.21 | $-0.21 | 1 |
| 2027-12-31 | $0.00 | $0.01 | $0.01 | 1 |
| 2028-03-31 | $-0.21 | $-0.20 | $-0.20 | 1 |
| 2028-06-30 | $-0.22 | $-0.21 | $-0.21 | 1 |
| 2028-09-30 | $-0.17 | $-0.16 | $-0.16 | 1 |
| 2028-12-31 | $0.09 | $0.09 | $0.09 | 1 |
Frequently Asked Questions
What is the analyst consensus for TMCI?
The consensus among 3 analysts covering Treace Medical Concepts, Inc. (TMCI) is Hold with an average price target of $3.00.
What is the highest price target for TMCI?
The highest price target for TMCI is $16.00, set by Ryan Zimmerman at BTIG on 2025-02-04.
What is the lowest price target for TMCI?
The lowest price target for TMCI is $3.00, set by Richard Newitter at Truist Financial on 2025-12-18.
How many analysts cover TMCI?
3 analysts have issued ratings for Treace Medical Concepts, Inc. in the past 12 months.
Is TMCI a buy or sell right now?
Based on 3 analyst ratings, TMCI has a consensus rating of Hold (2.67/5) with a -27.5% upside to the consensus target of $3.00.
What are the earnings estimates for TMCI?
Analysts estimate TMCI will report EPS of $-0.91 for the period ending 2026-12-31, with revenue estimated at $206M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.